-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
July 01, 2012 - Direct health effects of testing
Emotional, cognitive, social, behavioral re-
sponses to testing … Legal, ethical effects of testing
Costs
Outcome Origins
From Testing Process
From Test Results … Legal and ethical effect of testing. … Legal and ethical effects of testing. … Legal and ethical effects of testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - for
CYP2C19 variants and phenotypic testing for platelet reactivity,
focusing on standardizing testing … This appears to be a very rigorous review of platelet
function testing and CYP2C19 genetic testing for … We reviewed several studies comparing testing versus
no-testing strategies for tests measuring platelet … Use of phenotypic
testing (but not genetic testing) as a monitoring test can be
considered a variation … Pharmacokinetic and
pharmacodynamic testing (such as platelet function testing) in
healthy volunteers
-
effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research-protocol
-
effectivehealthcare.ahrq.gov/products/genetic-testing-developmental-disabilities/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
January 01, 2013 - Testing … The current strategy for diagnosing CD involves serial serologic and
histopathologic testing. … After initial evaluation and testing for iron, folate and vitamin B12
deficiencies and ruling out other … Objective 4 - Expected consequences of testing for CD (Celiac 4)
a. … What are the expected consequences of testing for CD in the following populations:
i.
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
March 29, 2016 - Peer Reviewer 1 Methods However it would be helpful to include testing vs no testing in
low risk groups … We identified no studies evaluating testing
versus no testing that met our inclusion
criteria. … testing as analyzed in this report. … There were no studies identified that
evaluated testing versus no testing in the
population of interest … No studies comparing testing
vs. no testing were identified.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing
Segal JB.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing
Segal JB.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
March 01, 2016 - While procalcitonin point-of-care testing reduced
antibiotic prescribing in adults, use of an adult … Clinical Interventions (Point-of-Care Testing):
��Procalcitonin point-of-care testing in adults reduced … ��Streptococcal antigen point-of-care testing (rapid strep
testing) reduced overall prescribing by 20 … ��Point-of-care testing for influenza in children had no
effect on antibiotic prescribing (���). … strep testing 3 RCTs ���
Inappropriate prescribing -33% Greater reduction with rapid strep testing 1
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
January 01, 2009 - Results of Topic Selection Process & Next Steps
Antinuclear autoantibody and rheumatoid factor testing … is interested in the diagnostic accuracy of antinuclear antibody (ANA)
and rheumatoid factor (RF) testing … clinical factors that may modify accuracy or benefits and
harms associated with obtaining ANA and RF testing … not limited to):
Patient referrals (i.e., to pediatric rheumatologists)
Additional diagnostic testing … (e.g., radiologic studies, laboratory testing, etc
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Fecal DNA Testing … (FOBT) or fecal immunohistochemical testing (FIT)
annually; and flexible sigmoidoscopy every 5 years … .
3
Fecal DNA testing detects molecular alterations associated with CRC development in
cellular … Question 6: Harms
What are the potential harms of fecal DNA testing? … FOBT = Fecal Occult-Blood Testing
USPSTF = U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - Intervention SFLC testing and SFLC testing in
combination with traditional testing. … SFLC testing and SFLC testing in combination with
traditional testing. … Intervention SFLC testing, metrics of SFLC testing,
frequency of SFLC testing.
SFLC testing. … SFLC testing and SFLC testing in
combination with traditional testing. … Intervention SFLC testing, metrics of SFLC testing, frequency of SFLC
testing
SFLC testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
March 14, 2012 - Whether it can replace or should
supersede other testing methods is controversial. … An advantage of colon scintigraphy is that testing can be completed
in 1 to 2 days. … Capsule testing cannot be performed in any
patient expected to have stricture or stenosis. … Other testing might be required to ensure that no
narrowing is present. … , then the next step in evaluation is transit testing with use of laxatives.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - the use of testing (e.g., genetic testing to determine CYP2C19 status or phenotypic testing of
platelet … Genetic testing for CYP2C19
ii. … Genetic testing for CYP2C19 followed by phenotypic testing for
platelet reactivity
iii. … Phenotypic testing for platelet reactivity
iv. No testing
b. … Potential test-and-treat strategies will include testing for CYP2C19 genetic
variants, testing for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults … Fecal
DNA Testing in Screening for Colorectal Cancer in Average-Risk Adults. … or soon
to be available testing. … or soon
to be available testing. … As the authors note, the
field of fecal DNA testing is rapidly evolving.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
July 01, 2012 - in cases that involve testing for heritable conditions. … 3b: How well does CYP450 testing predict drug efficacy? … Rather, family history-based testing is the paradigm that is
recommended to guide the use of BRCA testing … Task Force on Genetic Testing (NIH). … of confirmatory testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
March 20, 2021 - Database was linked to the HMC national PCR testing and COVID-19 hospitalization and severity database … All individuals for whom serological testing data was collected in Qatar Deceased persons tested for … Note: Symptomatic and asymptomatic PCR testing were widely available for employees, with data available … occurred at days 0 and 7; clearence testing was conducted day 28; then homes returned to "routine testing … followed by repeated weekly testing; non-residential students were subject to random surveillance testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
May 01, 2013 - We sought to
determine whether WMC testing is useful in conjunction
with or instead of other testing … testing. … Is WMC equivalent to conventional testing?
Is it superior? … The SOE was low regarding the effect of WMC testing
on treatment decisions based on ROM testing. … ROM testing involves exposure to
at least one x ray by definition.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
February 01, 2012 - Acceptability of Testing. … (of a program of testing, and harms
of testing due to diagnostic inaccuracies) and optimal
intervals … roles of fecal DNA testing. … Also, our review did not
include stool-based testing using RNA or other
genetic/genomic based testing … fecal DNA testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-261-postpartum-care-executive-summary.pdf
June 01, 2023 - • Healthcare Delivery Strategies – Coordination and Management of Care
o For screening/testing care … to oral glucose
tolerance testing up to 1 year postpartum but not random glucose testing or
hemoglobin … (Hb) A1c testing (moderate SoE). … For screening/testing care (3 studies of mail
and/or telephone reminders), testing reminders were associated … testing or
HbA1c testing (moderate SoE).